This specialized case study explores Kymanox’s comprehensive product development and Intellectual Property (IP) strategy for a reusable electromechanical autoinjector platform. Our team of SMEs collaborated closely with stakeholders to deliver measurable improvements across device design, manufacturing scalability, and patient-centric innovation.
CHALLENGE
SOLUTION
RESULTS
- Develop an electromechanical, reusable autoinjector platform device to serve multiple pharmaceutical companies.
- Identify and consolidate diverse device requirements from patients, healthcare providers, and manufacturing stakeholders.
- Establish a strong IP portfolio to protect innovations and enhance brand value.
- Formulate a comprehensive design and manufacturing strategy focusing on scalability and reliability.
- Gathered and synthesized device requirements from patients, providers, component manufacturers, automation vendors, contract fill and finish partners, and contract manufacturers.
- Built an industry-leading IP portfolio emphasizing patient experience and technology differentiation to boost pharmaceutical partners’ brand equity.
- Developed in-house expertise covering device design and manufacturing processes to maintain control over timelines and costs.
- Created innovative technologies including RFID/NFC syringe identification, Bluetooth connectivity, skin sensing capabilities, and pre-injection drug warming for enhanced usability.
- Established a robust IP portfolio with unique, patient-centric innovations.
- Delivered a scalable platform device boasting advanced features suitable for multiple pharmaceutical companies.
- Enhanced brand value and competitive differentiation for partners through superior patient experience and cutting-edge technological integration.